Trusted solutions
for healthcare.

Philipp Haas, Chairman of the Board of Directors and CEO of DEVA Holding, completed his MBA with a specialization in Banking at the University of St. Gallen, Faculty of Economics, Law and Business Administration. He speaks German, English, French, Spanish, Portuguese, Italian and Turkish fluently.

Having served as an investment consultant and executive since 1992, Philipp Haas has extensive experience in Eastern European markets, particularly in the Turkish market. He has taken part in numerous restructuring projects in Ukraine and Türkiye and, during the 1990s, served on the boards of directors on behalf of foreign corporate investors, including Rogan Brewery in Ukraine and Net Holding in Türkiye.

With extensive experience in the pharmaceutical industry, Philipp Haas has served as a consultant to funds operating in the pharmaceutical sector in developing markets and directed their investments toward Eastern Europe. Among these firms is Slovakopharma, later renamed Zentiva.

In addition to serving as Chairman of the Board of Directors of Eastpharma Ltd and DEVA Holding, Haas also serves as Chairman of the Board of Directors of Saba İlaç Sanayi ve Ticaret A.Ş., New Life Yaşam Sigorta A.Ş., and Eastpharma İlaç Üretim Pazarlama San. ve Tic. A.Ş., and as a member of the Board of Directors of Eastpharma S.a.r.l. He also serves as a manager in Devatis Ltd, Devatis GmbH, Devatis AG, Devatis de Mexico S. DE RL. DE C.V., Devatis Pty Ltd, Devatis Canada Inc., Devatis d.o.o. Belgrade, Devatis B.V., Devatis LLC, and Devatis UK Ltd., and as a member of the Board of Directors and CEO of Devatis Inc.

CFO of DEVA Holding, Mesut Çetin started his professional career within GEM Global Equities Management S.A., a fund management company, in 1999, and has served in various positions as clearing, research assistant, trader and management. Within the same group, he served actively in several private equity projects, and assumed the duty of project supervision in some projects.

Mesut Çetin is the member of the BOD in Eastpharma Ltd. and Saba İlaç Sanayi ve Ticaret A.Ş. He also performs the duty of CFO in various companies within the group.

Mesut Çetin is the graduate of Mathematics Teaching at Boğaziçi University and completed his EMBA program at Koç University.

Mr. Coombe-Tennant is the managing director of Port Tennant Co Ltd. and responsible for the company's equity and real estate investment operations. He is a director of Trophy Asset Management Ltd, which is the investment manager to two Asian equity funds and 100% owner of Trophy Property GP Ltd.

Between 1997 and 2001 Mr. Coombe-Tennant worked for the Hong Kong and London offices of Societe Generale where he specialized in global emerging markets and UK financial institutions. Prior to that he worked in Hong Kong for Jardine Fleming Securities in equity and sales research for five years.

He worked at the Economist Intelligence Unit as a banking and European markets consultant and at Euromoney Publications between 1988 and 1991. He worked at Cazenove & Co in the equity fund management division between 1980 and 1987.

Mr. Hoffmann is an attorney and consultant specialized in commercial law and in the establishment of international distribution networks for consumer goods.

Mr. Hoffmann worked for Roche in Switzerland, Argentina, Peru and as a Regional Manager of the Pharmaceutical Division in Hong Kong between 1983 and 1991.

Mr. Hoffmann holds a Licentiate of Law degree from the University of Basel in Switzerland.